IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nabriva Therapeutics AG

CUSIP: 62957M104 | 41 institutional holders

Quarters

Q3 2017Q2 2017Q1 2017Q4 2016Q3 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2017

Boxer Capital, LLC86,710
0.0% of portfolio›$710
StyleTurnoverLocationFiled
Boxer Capital, LLC
86,710$7100.0%N/AN/ASan Diego, CA2017-11-14